1. Yao, Xiaojuan, Chen, Ruiying, Chen, Hongting, Koleske, Anthony, Xiao, Xiao. 2024. Impact of Abl2/Arg deficiency on anxiety and depressive behaviors in mice. In Behavioural brain research, 468, 115022. doi:10.1016/j.bbr.2024.115022. https://pubmed.ncbi.nlm.nih.gov/38697301/
2. Liu, Yun, Shao, Chen, Zhu, Linqi, Cao, Hui, Shao, Shihe. 2018. High Expression of ABL2 Suppresses Apoptosis in Gastric Cancer. In Digestive diseases and sciences, 63, 2294-2300. doi:10.1007/s10620-018-5111-7. https://pubmed.ncbi.nlm.nih.gov/29767389/
3. Eadie, Laura N, Lagonik, Elias, Page, Elyse C, Hughes, Timothy P, White, Deborah L. . Asciminib is a novel inhibitor of ABL1 and ABL2 gene fusions in ALL but requires the ABL SH3 domain for efficacy. In Blood, 144, 1022-1026. doi:10.1182/blood.2024024776. https://pubmed.ncbi.nlm.nih.gov/38848536/
4. Jones, Jill K, Zhang, Hengshan, Lyne, Anne-Marie, Pendergast, Ann Marie, Thompson, Eric M. 2023. ABL1 and ABL2 promote medulloblastoma leptomeningeal dissemination. In Neuro-oncology advances, 5, vdad095. doi:10.1093/noajnl/vdad095. https://pubmed.ncbi.nlm.nih.gov/37781087/
5. Zhang, Gaolian, Xia, Meng, Guo, Jianhui, Zeng, Jing, Liang, Weibin. . microRNA-1296 Inhibits Glioma Cell Growth by Targeting ABL2. In Technology in cancer research & treatment, 20, 1533033821990009. doi:10.1177/1533033821990009. https://pubmed.ncbi.nlm.nih.gov/33550941/
智鼠故事 
